OraSure Technologies CFO Buys Over $66,000 in Company Stock

Kenneth Mcgrath's purchase represents a 4.11% increase in his ownership stake.

Mar. 17, 2026 at 12:21am

Got story updates? Submit your updates here. ›

OraSure Technologies, Inc. (NASDAQ:OSUR) Chief Financial Officer Kenneth Mcgrath purchased 22,021 shares of the company's stock on March 13th, 2026 at an average price of $3.00 per share, for a total transaction value of $66,063. This purchase increases Mcgrath's direct ownership in the company to 557,262 shares, valued at $1,671,786.

Why it matters

Insider purchases can be seen as a positive sign, as it indicates the CFO's confidence in the company's future prospects. OraSure Technologies is a medical diagnostics company known for its OraQuick rapid HIV test, and this purchase suggests the CFO believes the stock is undervalued at current levels.

The details

Mcgrath's purchase represents a 4.11% increase in his ownership stake in OraSure Technologies. The company's stock has traded between $2.08 and $4.22 over the past 12 months, and currently has a market capitalization of $216.38 million. OraSure reported a net loss in its most recent quarter, but the CFO's purchase signals optimism about the company's long-term prospects.

  • The stock purchase was made on Friday, March 13th, 2026.

The players

Kenneth Mcgrath

The Chief Financial Officer of OraSure Technologies, Inc.

OraSure Technologies, Inc.

A medical diagnostics company specializing in point-of-care and self-testing products, including the OraQuick rapid HIV test.

Got photos? Submit your photos here. ›

The takeaway

Insider purchases can be a positive signal for investors, as they suggest the company's leadership believes the stock is undervalued. The CFO's substantial purchase of OraSure Technologies shares indicates confidence in the company's long-term prospects, despite its recent financial performance.